Pasireotide in Cushing's disease
- PMID: 22646646
- DOI: 10.1056/NEJMc1204078
Pasireotide in Cushing's disease
Comment on
-
A 12-month phase 3 study of pasireotide in Cushing's disease.N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743. N Engl J Med. 2012. PMID: 22397653 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources